Join Now

Category Archives: BioUtah News

PolarityTE Reports Third Quarter 2022 Financial Results and Provides Business Update

By Natalie Themm | Published November 11, 2022

PolarityTE provided a business update and reported financial results for the quarterly period ended September 30, 2022.

| Tagged | Leave a comment

PolarityTE Confirms Receipt of Unsolicited, Non-Binding Offer to Acquire the Company

By Natalie Themm | Published November 9, 2022

PolarityTE confirmed that on November 1, 2022, it received an unsolicited, non-binding offer (followed by an amended offer on November 8, 2022) from Michael Brauser to acquire all of the outstanding common stock of the Company not owned by him for $1.25 per share in cash.

| Tagged | Leave a comment

Clene Announces $10.8 Million Registered Direct Offering and $5 Million Debt Facility from the State of Maryland

By Natalie Themm | Published November 2, 2022

Clene announced that it has entered into a securities purchase agreement with certain existing stockholders.

| Tagged | Leave a comment

Clene Reports Topline Results Demonstrating Survival Signal for CNM-Au8® in Healey ALS Platform Trial

By Natalie Themm | Published November 2, 2022

The primary endpoint of adjusted ALSFRS-R and secondary endpoints of CAFS and SVC were not met at 24 weeks Prespecified exploratory analyses of the secondary survival endpoint for the 30 mg dose demonstrated a >90% reduction in risk of death or risk of death/permanently assisted ventilation at 24 weeks Survival signal consistent with prior results […]

| Tagged | Leave a comment

Myriad Genetics Expands Consumer Access to Genetic Testing with Acquisition of Gateway Genomics and Its Market-Leading SneakPeek® Early Gender DNA Test

By Natalie Themm | Published November 2, 2022

$67.5 million tuck-in acquisition strengthens Myriad’s Women’s Health portfolio of prenatal products.

| Tagged | Leave a comment

Myriad Genetics Reports Third Quarter Financial Results

By Natalie Themm | Published November 2, 2022

Myriad Genetics announced financial results for its third quarter ended September 30, 2022 and provided an update on business performance.

| Tagged | Leave a comment

Renalytix Reports Full Year Fiscal 2022 Results

By Natalie Themm | Published November 1, 2022

Renalytix announced its full year results for the twelve months ended 30 June 2022.

| Tagged | Leave a comment

Merit Medical Reports Results for Quarter Ended September 30, 2022

By Natalie Themm | Published November 1, 2022

Merit Medical Systems announced revenue of $287.2 million for the quarter ended September 30, 2022.

| Tagged | Leave a comment

UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2022

By Natalie Themm | Published October 27, 2022

UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2022

| Tagged | Leave a comment

KidneyIntelX Medicare Update

By Natalie Themm | Published October 25, 2022

Renalytix announced that the Federal Medicare Administrative Contractor (MAC) National Government Services (NGS) has initiated payment of claims for KidneyIntelX testing for patients with Medicare coverage.

| Tagged | Leave a comment

15th Annual 2022 Women Tech Award Recipients

By Natalie Themm | Published October 19, 2022

The Women’s Tech Council announced eight award recipients from its twenty one finalists.

| Tagged | Leave a comment

Geneial Receives $2.3M NIH Grant

By Natalie Themm | Published October 19, 2022

Geneial announces a multimillion dollar, non-dilutive award from the National Human Genome Research Institute to fund the development of their secure, decentralized platform.

| Tagged | Leave a comment

A Special Thanks To Our Legacy and Platinum Elite Members